COVID-19Regulatory

HHS launches public-private partnership to develop vaccines, therapies to treat coronavirus

April 17, 2020 / By Brooke Singman | Fox News

The Department of Health and Human Services on Friday announced plans to launch a new public-private partnership to develop a national strategy to create vaccines and therapies to treat the novel coronavirus.

On Friday, the National Institutes of Health and the Foundation for NIH announced the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership.

More than a dozen biopharmaceutical companies, HHS’s Biomedical Advanced Research and Development Authority, the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration and the European Medicines Agency will partner to develop a strategy for a coordinated research response to the COVID-19 pandemic.

“The ACTIVE partnership will bring new levels of coordination and speed to public and private work on therapies and vaccines for COVID-19—work that NIH, HHS, and the Trump administration began literally days after the coronavirus threat was identified in China in January,” HHS Secretary Alex Azar said in a statement Friday.

READ THE REST HERE

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button